1 Product identity
Ingredient risk
1 ingredient to use with caution
Vitamin C 250 mg
BrandAvPAK→Vitamin Tablet or Pill 7 ingredients 1 caution DSLD #271388Net contents: 50 Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2022-06-16
2 Ingredients (7)
IngredientGroupSafety
Microcrystalline CelluloseCellulose—
Stearic AcidStearic Acid—
StarchStarch—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Vitamin C — Generally Safe
⚠ GI distress at high doses
⚠ Kidney stones risk >1g/day
Sodium — Limited Evidence
⚠ Hypertension
⚠ Fluid retention
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
Silicon — Generally Safe
⚠ Very low toxicity
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID271388
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2022-06-16
6 More from AvPAK
View AvPAK Safety Scorecard → 14 products
A 3000 mcgCalcium 600+D3Calcium Citrate Maximum +D3Chewable C 500 mgFolic Acid 800 mcgFolic Acid 800 mcg7 Cite this page
Vancouver
Pkhakadze G. Vitamin C 250 mg — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Jun 24]. Available from: https://supplement.ge/products/vitamin-c-250-mg-271388/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG